Literature DB >> 15952029

Placement of baclofen pumps through the foramen magnum and upper cervical spine.

Kristine Dziurzynski1, Deborah Mcleish, Michael Ward, Bermans J Iskandar.   

Abstract

INTRODUCTION: The baclofen pump has been utilized in children with refractory spasticity. However, in children with prior lumbar fusion, the implantation of such a device is difficult and fraught with complications. As an alternative to placing the pump catheter through the lumbar spine, we report our experience with placement of the catheter in the spinal canal via a cervical approach through the foramen magnum.
METHODS: We have followed three patients with prior lumbar fusion and refractory spasticity, each of whom has undergone placement of the intrathecal component of a baclofen pump via the foramen magnum. Appropriate positioning of the catheter tip at the T6 spinal level was determined using intraoperative fluoroscopy. The catheter was then tunneled to the pump in the abdominal wall.
RESULTS: All patients experienced a significant decrease in the severity of spasticity with pump placement. The pumps continued to function properly over a follow-up period of 24, 24, and 44 months respectively. In one patient, the catheter recoiled into the subcutaneous tissues several months after its placement, thus necessitating repositioning. One of the pumps was removed 2 years later secondary to a VP shunt infection. However, there were no immediate complications related to placement of the spinal catheter.
CONCLUSIONS: Placement of the intraspinal component of a baclofen pump via the foramen magnum is a viable alternative for patients with spastic quadriparesis with prior lumbar fusion. The tip of the spinal catheter can be positioned in the thoracic region in a similar manner to the placement traditional lumbar pumps. In our series, there were no adverse sequelae related to the surgery or catheter positioning.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15952029     DOI: 10.1007/s00381-004-1129-6

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  11 in total

1.  The distribution of medication along the spinal canal after chronic intrathecal administration.

Authors:  J S Kroin; A Ali; M York; R D Penn
Journal:  Neurosurgery       Date:  1993-08       Impact factor: 4.654

2.  Cisternoatrial, ventriculocisternal, and other cisternal shunts simplified. A percutaneous technique.

Authors:  R F Spetzler; P R Weinstein; N Chater; C B Wilson
Journal:  J Neurosurg       Date:  1977-08       Impact factor: 5.115

3.  Long-term safety and efficacy of continuous intrathecal baclofen.

Authors:  William M Campbell; Anne Ferrel; John F McLaughlin; Gerald A Grant; John D Loeser; Catherine Graubert; Kristie Bjornson
Journal:  Dev Med Child Neurol       Date:  2002-10       Impact factor: 5.449

4.  What is a Torkildsen shunt?

Authors:  M S Alp
Journal:  Surg Neurol       Date:  1995-04

5.  Percutaneous ventriculocisternal shunt. Technical note.

Authors:  J L Fox; O Al-Mefty
Journal:  Surg Neurol       Date:  1985-08

6.  Cervical-peritoneal shunt in the treatment of pseudotumor cerebri. Technical cerebri. Technical note.

Authors:  R A Beatty
Journal:  J Neurosurg       Date:  1982-12       Impact factor: 5.115

7.  Functional assessment following intrathecal baclofen therapy in children with spastic cerebral palsy.

Authors:  Yasser Awaad; Hassan Tayem; Sharon Munoz; Steven Ham; Anne Marie Michon; Rania Awaad
Journal:  J Child Neurol       Date:  2003-01       Impact factor: 1.987

8.  Midthoracic catheter tip placement for intrathecal baclofen administration in children with quadriparetic spasticity.

Authors:  P A Grabb; S Guin-Renfroe; J M Meythaler
Journal:  Neurosurgery       Date:  1999-10       Impact factor: 4.654

9.  Continuous intrathecal baclofen infusion for spasticity of cerebral origin.

Authors:  A L Albright; W B Barron; M P Fasick; P Polinko; J Janosky
Journal:  JAMA       Date:  1993-11-24       Impact factor: 56.272

10.  Complications of intrathecal baclofen pumps in children.

Authors:  Judith L Gooch; Wende A Oberg; Barbara Grams; Lorrie A Ward; Marion L Walker
Journal:  Pediatr Neurosurg       Date:  2003-07       Impact factor: 1.162

View more
  3 in total

1.  Intrathecal baclofen therapy for spasticity of cerebral origin--does the position of the intrathecal catheter matter?

Authors:  Gnanamurthy Sivakumar; Yoong Yap; Mekidm Tsegaye; Michael Vloeberghs
Journal:  Childs Nerv Syst       Date:  2010-03-20       Impact factor: 1.475

2.  Cervical catheter placement for intrathecal baclofen test dose: is it safe?

Authors:  Samiul Muquit; Ismail Ughratdar; Harshal Ingale; Michael Vloeberghs
Journal:  Childs Nerv Syst       Date:  2012-02-12       Impact factor: 1.475

3.  A numerical investigation of intrathecal isobaric drug dispersion within the cervical subarachnoid space.

Authors:  Per Thomas Haga; Giulia Pizzichelli; Mikael Mortensen; Miroslav Kuchta; Soroush Heidari Pahlavian; Edoardo Sinibaldi; Bryn A Martin; Kent-Andre Mardal
Journal:  PLoS One       Date:  2017-03-15       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.